United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street NE
Washington, DC 20549
|
Attention:
|
Jeffrey P. Riedler
Assistant Director
|
Re:
|
AspenBio Pharma, Inc.
Preliminary Proxy Statement
Filed June 1, 2011
File No. 001-33675
|
1.
|
Please revise your disclosure to describe any plans, arrangements or understandings, written or oral, relating to the issuance of any of the newly authorized shares that would be available as a result of the proposed reverse stock split. If you have no such plans, arrangements or understandings, please revise your disclosure to so state.
|
·
|
the Company is responsible for the adequacy and accuracy of the disclosure in the filing;
|
·
|
staff comments or changes to disclosure in response to staff comments in the filing do not foreclose the Commission from taking any action with respect to the filing; and
|
·
|
the Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
|
|
Jeffrey G. McGonegal
|
%THLM=8XXK$81H_E+,2+B M%(;219S&O9K56NP179P"E660),24[]?C/W=NH)UK>@3^QXCSV)E6RT.5H.M5 M0]@K80B)22`6]_:"58;/[J?X/`X^*X5\)C9()["V;,]F:W/*D?Q(TDLC.>J; M/51VT!LGULDDDF\Y#Q]VKD:PL4;,-F`LR"2%PZ]E)5AL?N"""/V((Y,X#CCC M@....`XXXX#CCC@....`XXXX#CCC@....!\_H>&7J=;((+8^6]DYK$I%B1HQ M6EL?,Z")PR=M?8=*`P))Y#/@64."PF*2[54>/N\V+M,"T@=&U620=0#&L1*. M![?0(*$ MS_'`K?*:.2ROC\E*D:<-BP!'.9B[*L;#4@0KINQ4D!O6M[UZURC;QB>3)U+> M36BV-@PMC%SU:4)R_C]=A5;'Y1YE>X]D((>D1D4@:TP/4C?8:]?G?H*W#XWRA M_$XJ$F4-25X+L*VK2?/_;99@/>]DU];P"2KCZ\,*8U:M; M*-?BQ#=FJ)$]-JTD`8CTK&228_81V<@@[+'Z%)8ABFBADE199=_&C,`SZ&SH M?OH O8>";&PU5R.,GR'=;)D,;13I$8]%%V-2`]MC\$=1^>!0^0^# MYNCXUX_0Q60K6X<9;Q_Q134))6B9;L;-(A$PU&B>@I!*QHRAQV)Y>^7^+YGR M:L8+MO'-&DMGX(Q$Z",.G6"?MV+?-$>Q&NH);8ZE58;#^H4VCAD%N`Q3:^)Q M(NI-D`=3OW[('K]R.4K^4PCS<8$?2F%,=+>EL"T"\3)(B%'37VC3[[%OV/KU MO@9^SXM-:\TA:&;(R4UR$.7OS6%C2/YXJP@18`$#DOJ-G.R@",HT6(%-C?"% M^E=[$V=3%XRC4Q^*D^*,W6$-A9TD,8BZZ5HX%42+O2N7&FWSZB,I0+PZO5#\ MP3XO[R_W.^^O7W[WU;6OSH_QRO\`+\\N"\:SN2@2&W9Q5.2X];YNA*JC-HD` ME=A6T=>]<"'X!B+F+QV0L90%+^3NRWYH=JWP]@JHA*_;V$:)VZ^B_ J_#)+]3#\4;F-W^0=5<'14G]B#ZUQ;O5*E7ZFU:@@K'7]V20*GO\`'L^O M?`E\ [1!QW"_R5_.O]^<%RM!PI2]48,R(O]Y3MG&T`]_E@ M00/W!]<"PXXXX#CCC@....`XXXX#CCC@....`XXXX'S=OT]E.59H[D2XSZVQ MNJT?8&C9`ELUR/P?DL@-O]D'4'\CG'+_`*:/ BCIRVVFCK=''6&R@C MOPDAM$2Z653K:R`G\$\<<"5F?`9K.=N7\5<%'Y+4-V+IZ,4[)]/:<:'Y:L%" M?PY9C^1SOE/' "G@UK8:Y8$%,2/'&U1J[PQC_VR%8=O:@==>@>..!3 M4/`LUBKOBJ59<79HX5:G:20M%/*8XK,3KOHY**+`,:]O0#*?\N_.53P#/U,= MCHU_H -U!B`#J00?Q^`0?V%92_3_.+7H5+D&(EKTL*V&,D=V: M.2R/FA82DK$#&Y$;MZ9NKL/;>^..!&L^,7\QG<_XYDABK5B[X[3AM79`%>)S M8N,9(XUC"NX+*Y;^W]X1M#MI9V?\$S^2LYUXDPD*WL7E<9"(Y&C`%J1'21@( M=]OM8OMFVVRNNQ`<<"?F/" 3^G2QTLO X9MK!&.H_Y ^I[!@?SV4>OW#C@?95WH;`!_?7/WC 9C@....`XXXX#CCC@....`XXXX#CCC@?_V3\_ ` end